Syncom Formulations India Q4 Results

  • BSE: 524470
  • NSE: SYNCOMF
  • ISIN: INE312C01025
  • Sector: Biotechnology & Drugs
BSE
19.580.07 (0.36%)
Volume4.85 L
Updated: Mon 25 Nov, 2024 | 15:55:07
NSE
19.580.08 (0.41%)
Volume1.97 M
Updated: Mon 25 Nov, 2024 | 15:40:23
Today: 19.51
20.31
52-Wk: 9.80
27.94

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Syncom Formulations India Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 74.5757.38-%60.98-%
    Selling/ General/ Admin Expenses Total 8.697.26-%7.20-%
    Depreciation/ Amortization 1.301.20-%1.17-%
    Other Operating Expenses Total 13.769.45-%10.45-%
    Total Operating Expense 66.4552.68-%56.17-%
    Operating Income 8.134.70-%4.81-%
    Net Income Before Taxes 10.035.97-%10.28-%
    Net Income 7.404.14-%8.47-%
    Diluted Normalized EPS 0.100.06-%0.10-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts